5.00 USD
↘ 0.08 (1.57%)AT CLOSE (11:59 AM EDT)
ImageneBio, Inc. Common Stock
IMANASDAQ • USD
5.04
↗ 0.04 (0.70%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
5.04
↗ 0.04 (0.70%)
Market: CLOSED
Shares of ImageneBio, Inc. Common Stock (IMA) are trading at $5.06. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMA appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 14, 2026.
Open?$5.22
High?$5.39
Low?$5.00
Prev. Close?$5.08
Volume?15.0K
Avg. Volume?12.2K
VWAP?$5.13
Rel. Volume?1.23x
Bid / Ask
Bid?$3.91 × 100
Ask?$6.53 × 100
Spread?$2.62
Midpoint?$5.22
Valuation & Ratios
Market Cap?57.7M
Shares Out?11.4M
Float?9.4M
Float %?83.2%
P/E Ratio?N/A
P/B Ratio?0.41
EPS?-$4.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Employees
18
Market Cap
57.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2025-07-28
Address
12526 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: 857-343-8292
SAN DIEGO, CA 92130
Phone: 857-343-8292
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?10
Momentum?50
Short Sent.?88
Piotroski F-Score?0/9Weak
Altman Z-Score?0.94Distress
Confidence?23%Very Low
Short InterestModerate
Short % of Float?0.42%Low
Short Interest?39.4K
Days to Cover?3.4
Free Float9.4M
Avg Daily Volume11.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?21.47Strong
Quick Ratio?21.47Strong
Cash Ratio?14.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.41CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.6CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.5%WEAK▾
S&P3
ROA?-35.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-57733000
Enterprise Value?$-37011604
Fundamentals ratios updated end of day